Healthcare
Live Price
Offline$0.0006
+0.00% today
Window Change
+200.00%
Window
Jul 23, 2025 → Jun 17, 2026
Coverage: 227 bars · Jul 23, 2025 → Jun 17, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
RegeneRx Biopharmaceuticals, Inc. (RGRX) is a Healthcare stock with listed on OTC. The stock last traded around $0.00 and up 200.0% across the available one-year price window (Jul 23, 2025 → Jun 17, 2026). Baseline metrics include revenue growth of 0.0%, EPS growth of -7094.2%, a dividend yield of 0.0%. What stands out right now is revenue 0.0%, EPS -7094.2%, free cash flow +5.0% with operating margin -1826.4% and ROIC 1654.7%. Valuation is more restrained than many high-expectation growth names at price/sales 0.0. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines RGRX price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
RGRX
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
RGRX Max Drawdown
-99.88%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for RGRX and SPY.
Powered by FMP stock_dividend. Includes historical ex-dates, pay dates, and payout amounts.
Dividend Yield
No active yield
Trailing 12M Payout
$0.00
Last Payout
—
Next Step
Dividend yield means more when it is matched with payout durability, earnings quality, and sector context.